Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI

Abstract Although most patients with mild traumatic brain injury (mTBI) experience rapid recovery, some report persistent chronic symptoms such as cognitive dysfunction. One risk factor for prolonged recovery after mTBI is early life stress (ELS). We hypothesized that ELS mediates prolonged cognitiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiola Placeres-Uray, Aditi S. Gorthy, Maria Dominguez Torres, Coleen M. Atkins
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-025-03512-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342392991219712
author Fabiola Placeres-Uray
Aditi S. Gorthy
Maria Dominguez Torres
Coleen M. Atkins
author_facet Fabiola Placeres-Uray
Aditi S. Gorthy
Maria Dominguez Torres
Coleen M. Atkins
author_sort Fabiola Placeres-Uray
collection DOAJ
description Abstract Although most patients with mild traumatic brain injury (mTBI) experience rapid recovery, some report persistent chronic symptoms such as cognitive dysfunction. One risk factor for prolonged recovery after mTBI is early life stress (ELS). We hypothesized that ELS mediates prolonged cognitive dysfunction after mTBI by exacerbating the NRLP3 inflammasome signaling pathway, and that these effects could be reversed by inhibiting NLRP3. Methods To test this hypothesis, Sprague Dawley rat pups were maternally separated for 3 h daily from P2-P14. Subsequently, the rats underwent a mild-to-moderate fluid percussion brain injury (1.4 atm) or sham surgery during young adulthood and were then treated with either the NLRP3 inhibitor MCC950 or vehicle. Results We found that ELS significantly increased microglia and macrophage cell numbers within the hippocampus during mTBI recovery. Quantitative PCR demonstrated that the combination of ELS and mTBI significantly increased levels of HMGB1, TLR4, NLRP3, caspase 1, and IL-1β mRNA levels in the ipsilateral hippocampus at 24 h after injury. This upregulation was persistent and TLR4, NLRP3, caspase 1, and IL-1β levels remained elevated for up to 2 months after injury. Inhibition of the NLRP3 inflammasome with MCC950 reduced this upregulation both 24 h and 2 months after injury. Hippocampal microglia isolated by fluorescence-activated cell sorting demonstrated increased levels of NLRP3 after ELS alone, but not IL-1β. The upregulation in microglial IL-1β required the combination of ELS and mTBI and was ameliorated with MCC950. Additionally, MCC950 treatment improved glucocorticoid receptor downregulation in the hippocampus after ELS, mTBI alone and mTBI + ELS. The combinatory insult of ELS and mTBI also impaired associative fear memory which was prevented with MCC950 treatment. Conclusion In summary, ELS limits recovery after mTBI by upregulating the expression of NLRP3 inflammasome signaling molecules in microglia. Inhibition of NLRP3 is an effective therapeutic for treating chronic cognitive deficits after ELS and mTBI.
format Article
id doaj-art-5e5bb99222cf4b7985e4b0bcd4f7cd63
institution Kabale University
issn 1742-2094
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj-art-5e5bb99222cf4b7985e4b0bcd4f7cd632025-08-20T03:43:25ZengBMCJournal of Neuroinflammation1742-20942025-07-0122111310.1186/s12974-025-03512-5Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBIFabiola Placeres-Uray0Aditi S. Gorthy1Maria Dominguez Torres2Coleen M. Atkins3The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineThe Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineThe Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineThe Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineAbstract Although most patients with mild traumatic brain injury (mTBI) experience rapid recovery, some report persistent chronic symptoms such as cognitive dysfunction. One risk factor for prolonged recovery after mTBI is early life stress (ELS). We hypothesized that ELS mediates prolonged cognitive dysfunction after mTBI by exacerbating the NRLP3 inflammasome signaling pathway, and that these effects could be reversed by inhibiting NLRP3. Methods To test this hypothesis, Sprague Dawley rat pups were maternally separated for 3 h daily from P2-P14. Subsequently, the rats underwent a mild-to-moderate fluid percussion brain injury (1.4 atm) or sham surgery during young adulthood and were then treated with either the NLRP3 inhibitor MCC950 or vehicle. Results We found that ELS significantly increased microglia and macrophage cell numbers within the hippocampus during mTBI recovery. Quantitative PCR demonstrated that the combination of ELS and mTBI significantly increased levels of HMGB1, TLR4, NLRP3, caspase 1, and IL-1β mRNA levels in the ipsilateral hippocampus at 24 h after injury. This upregulation was persistent and TLR4, NLRP3, caspase 1, and IL-1β levels remained elevated for up to 2 months after injury. Inhibition of the NLRP3 inflammasome with MCC950 reduced this upregulation both 24 h and 2 months after injury. Hippocampal microglia isolated by fluorescence-activated cell sorting demonstrated increased levels of NLRP3 after ELS alone, but not IL-1β. The upregulation in microglial IL-1β required the combination of ELS and mTBI and was ameliorated with MCC950. Additionally, MCC950 treatment improved glucocorticoid receptor downregulation in the hippocampus after ELS, mTBI alone and mTBI + ELS. The combinatory insult of ELS and mTBI also impaired associative fear memory which was prevented with MCC950 treatment. Conclusion In summary, ELS limits recovery after mTBI by upregulating the expression of NLRP3 inflammasome signaling molecules in microglia. Inhibition of NLRP3 is an effective therapeutic for treating chronic cognitive deficits after ELS and mTBI.https://doi.org/10.1186/s12974-025-03512-5Early life stressFluid-percussion brain injuryMCC950MicrogliaTraumatic brain injury
spellingShingle Fabiola Placeres-Uray
Aditi S. Gorthy
Maria Dominguez Torres
Coleen M. Atkins
Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
Journal of Neuroinflammation
Early life stress
Fluid-percussion brain injury
MCC950
Microglia
Traumatic brain injury
title Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
title_full Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
title_fullStr Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
title_full_unstemmed Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
title_short Inhibition of microglia priming by NLRP3 reduces the impact of early life stress and mild TBI
title_sort inhibition of microglia priming by nlrp3 reduces the impact of early life stress and mild tbi
topic Early life stress
Fluid-percussion brain injury
MCC950
Microglia
Traumatic brain injury
url https://doi.org/10.1186/s12974-025-03512-5
work_keys_str_mv AT fabiolaplaceresuray inhibitionofmicrogliaprimingbynlrp3reducestheimpactofearlylifestressandmildtbi
AT aditisgorthy inhibitionofmicrogliaprimingbynlrp3reducestheimpactofearlylifestressandmildtbi
AT mariadomingueztorres inhibitionofmicrogliaprimingbynlrp3reducestheimpactofearlylifestressandmildtbi
AT coleenmatkins inhibitionofmicrogliaprimingbynlrp3reducestheimpactofearlylifestressandmildtbi